Therapixel receives FDA 510(k) Clearance for use of its AI-based Breast Cancer Screening Software MammoScreen on Digital Breast Tomosynthesis
SYNOPSIS: New 510(k) clearance expands the use of MammoScreen from 2D to 3D mammography, opening up the entire breast cancer screening market.…